Yanni Souroutzidis

Stock Analyst at Cantor Fitzgerald

(2.59)
# 2,035
Out of 5,154 analysts
1
Total ratings
100%
Success rate
45.93%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Yanni Souroutzidis

Karyopharm Therapeutics
Feb 5, 2026
Initiates: Overweight
Price Target: n/a
Current: $8.77
Upside: -